Credit: ivanko80/Adobe Stock

The battle over access to a key drug used for medication abortions continues to heat up, both in a Texas courtroom and in the U.S. Senate.

Today, U.S. District Judge Matthew Kacsmaryk will hear arguments today in a case involving the U.S. Food and Drug Administration’s decades-old approval of the drug mifepristone, one of two medications used to terminate an early pregnancy. The plaintiffs asked Kacsmaryk to order the FDA to withdraw its approval of the drug, arguing that the agency mistakenly approved the drug under a regulation that allows accelerated approval of medications for “serious or life-threatening illnesses.”

Complete your profile to continue reading and get FREE access to BenefitsPRO.com, part of your ALM digital membership.

Your access to unlimited BenefitsPRO.com content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical BenefitsPRO.com information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com

Already have an account?

 

BenefitsPRO

Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!

  • Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
  • Exclusive discounts on BenefitsPRO.com and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2023 ALM Global, LLC. All Rights Reserved.